The Hepatic Stellate Cells (HSCs) and Adipose Derived Stem Progenitor Cells (ASCs): are they Critical Multitargeted Endogenous Metabolic Modulators in syndrome X and EMS? Letter to Editor-Reference-Cited by-同舟云学术

The Hepatic Stellate Cells (HSCs) and Adipose Derived Stem Progenitor Cells (ASCs): are they Critical Multitargeted Endogenous Metabolic Modulators in syndrome X and EMS? Letter to Editor

Published:2021-08-13 Issue:5 Volume:17 Page:1931-1933
ISSN:2629-3269
Container-title:Stem Cell Reviews and Reports
language:en
Short-container-title:Stem Cell Rev and Rep

Author:

Marycz Krzysztof^ORCID

Funder

narodowe centrum nauki

narodowy fundusz ochrony środowiska i gospodarki wodnej

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12015-021-10233-8.pdf

Reference7 articles.

1. Bourebaba, L., Łyczko, J., Alicka, M., Bourebaba, N., Szumny, A., Fal, A. M., & Marycz, K. (2020). Inhibition of Protein-Tyrosine Phosphatase PTP1B and LMPTP Promotes Palmitate/Oleate-Challenged HepG2 Cell Survival by Reducing Lipoapoptosis, Improving Mitochondrial Dynamics and Mitigating Oxidative and Endoplasmic Reticulum Stress. Journal of Clinical Medicine, 9(5), 1294. https://doi.org/10.3390/jcm9051294.

2. Marycz, K., Szłapka-Kosarzewska, J., Geburek, F., & Kornicka-Garbowska, K. (2019). Systemic Administration of Rejuvenated Adipose-Derived Mesenchymal Stem Cells Improves Liver Metabolism in Equine Metabolic Syndrome (EMS)- New Approach in Veterinary Regenerative Medicine. Stem Cell Reviews and Reports, 15(6), 842–850. https://doi.org/10.1007/s12015-019-09913-3.

3. Bourebaba, L., Kornicka-Garbowska, K., Al Naem, M., Röcken, M., Łyczko, J., & Marycz, K. (2021). MSI-1436 improves EMS adipose derived progenitor stem cells in the course of adipogenic differentiation through modulation of ER stress, apoptosis, and oxidative stress. Stem Cell Research & Therapy, 12(1), 97. https://doi.org/10.1186/s13287-020-02102-x.

4. Bourebaba, N., & Marycz, K. (2021). Hepatic stellate cells role in the course of metabolic disorders development – A molecular overview. Pharmacological Research, 170, 105739. https://doi.org/10.1016/j.phrs.2021.105739.

5. Al Naem, M., Bourebaba, L., Kucharczyk, K., Röcken, M., & Marycz, K. (2020). Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders. Stem Cell Reviews and Reports, 16(2), 301–322. https://doi.org/10.1007/s12015-019-09932-0.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of adipose-derived stromal vascular fraction in veterinary practice;Veterinary Quarterly;2022-08-08

2. Mesenchymal Stem Cells Therapeutic Applications in Endocrine Disorders;Therapeutic Applications of Mesenchymal Stem Cells in Veterinary Medicine;2022